The results of an interventional trial presented today at the European League Against Rheumatism Annual Congress (EULAR 2015) showed that use of the disease-modifying anti-rheumatic drug ...
Positive feedback from FDA suggests an indication from perioperative pain to all mild-to-moderate acute pain, significantly expanding clinical and commercial potential IND-enabling studies currently ...
Nonnarcotic pain medications aren’t addictive and can be used to manage mild to moderate pain. Being in pain can be an exhausting and upsetting experience. Sometimes the reasons you’re in pain aren’t ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results